Improved delivery of methoxsalen.

Area of Science:

• Pharmacology
• Drug Delivery Systems
• Dermatology

Background:

• Methoxsalen is a medication used in PUVA therapy for psoriasis.
• The bioavailability of orally administered methoxsalen can be variable.
• Formulation significantly impacts drug absorption and therapeutic efficacy.

Purpose of the Study:

• To compare the bioavailability of methoxsalen when administered as a solution versus a suspension.
• To evaluate the pharmacokinetic profile of methoxsalen in different formulations.
• To discuss the implications of formulation-dependent bioavailability for psoriasis treatment.

Main Methods:

• Pharmacokinetic studies were conducted in rats and dogs.
• Methoxsalen was administered orally in both solution and suspension forms.
• Blood samples were analyzed to determine methoxsalen concentrations over time.

Main Results:

• Oral administration of methoxsalen in solution resulted in significantly improved bioavailability compared to suspension.
• Earlier and higher peak plasma concentrations of methoxsalen were observed with the solution formulation in both species.
• The solution formulation demonstrated a more favorable pharmacokinetic profile.

Conclusions:

• Formulation as a solution enhances methoxsalen bioavailability and absorption.
• Optimizing methoxsalen formulation may improve therapeutic outcomes in psoriasis patients.
• Further clinical studies are warranted to confirm these findings in humans.